Contact
Home • Our expertise • Commercial

Commercial Strategy.

Commercialize with confidence to create a real, lasting impact.

Get in touch with an expert
Scroll

What we do.

We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Grounded in scientific and strategic excellence and delivered by experts with deep therapeutic area expertise, our solutions help maximize the commercial success of your product and portfolio to ensure the greatest clinical impact to patients.

How we help.

Our pharmaceutical commercialization services span the product lifecycle, serving many of the most innovative and fastest-growing products of the last decade.

With our comprehensive understanding of the clinical landscape, commercial landscape, and interdisciplinary approach, we help our clients make decisions that maximize their product’s impact.

Learn about our Centers of Excellence

At each phase of the product journey, our strategies will help you commercialize with confidence.

  • Portfolio strategy
  • BD scans and due diligence
  • Early commercial strategic planning
  • Market opportunity identification
  • Positioning and branding strategy
  • Customer engagement strategy
  • Data strategy
  • Integrated data analytics

Commercial services.

Portfolio, Licensing & Development

Prepare for lasting clinical and commercial success when you build and optimize your product and portfolio value with us.

Learn more

Commercialization & Growth

Rely on our expertise to guide your product and franchise strategy at every point of the commercialization journey from pre-launch to end-of-lifecycle.

Learn more

Data Strategy, Analytics & AI

Leverage the sea of data and life science analytics available today to guide your product strategy and optimize customer engagement.

Learn more

Case studies in related areas.

See how we’re helping clients solve key challenges and deliver on their ambitions.

More insights

Growth strategy in an evolving market: Market sizing and strategic planning

A biopharma company sought unified view on market dynamics and strategic opportunities for its business decisions.

Read more

Integrated data platform creation

The client team wanted to create a best-in-class data platform to support insights, forecasting, targeting, next generation data modeling.

Read more

Early oncology portfolio execution roadmap

We developed a forward-looking early development program evaluation tool that identifies key inflection points for early oncology portfolio.

Read more

Our Commercial practice lead.

Matthew Riordan

Chief Operating Officer, Commercial Practice Lead

Read bio

About Matthew.

Matt serves clients within the life science industry on commercial strategy issues. He has led projects that leverage detailed and integrative analytics to inform critical strategic decisions, focused on market opportunity identification (including physician and patient segmentation), product positioning and launch strategies, and customer engagement model design. He has deep expertise in complex hematology/ oncology, immunology, and orphan disease markets, with significant experience in cardiovascular, CNS, and infectious disease markets. He has led multiple internal knowledge development initiatives for the firm, including research on state-of-the art approaches to segmentation, understanding adherence from a business perspective, and integrating clinical and access research to inform comprehensive assessments of market potential.

Latest thinking.

Get the latest insights and perspectives from our experts.

View all resources

Sunny side up – Biotech funding – 2025 & Beyond

Putnam shares key questions to consider in preparation of advancing trials and deals that have been put on hold.

Read more

Emerging trends in complement therapeutics

Putnam has a proven track record of delivering superior strategic support to pharma leaders in developing strategies...

Read more

Putnam’s Demand Calibration Tool to increase demand estimate precision

Putnam's Demand Calibration Tool enhances demand estimation accuracy by leveraging insights from 200+ studies across 50+ diseases and markets

Read more

Using AssetNav to Navigate Therapeutic Landscapes with Confidence

We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today